1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Chugai Pharmaceutical Co., Ltd
  6. News
  7. Summary
    4519   JP3519400000

CHUGAI PHARMACEUTICAL CO., LTD

(4519)
  Report
Delayed Japan Exchange  -  05/27 02:00:00 am EDT
3429.00 JPY   -0.46%
05/26Chugai Launches Vabysmo Intravitreal Injection 120 mg/mL for the Treatment of Age-related Macular Degeneration Associated with Subfoveal Choroidal Neovascularization and Diabetic Macular Edema
AQ
05/18Judgement On The First Drug Patent Linkage Lawsuit In China Is Issued
AQ
04/28Chugai Pharmaceutical Co., Ltd. - Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CHUGAI PHARMACEUTICAL CO., LTD. : Ex-dividend day for final dividend

12/29/2021 EDT

A final dividend is removed today from Chugai Pharmaceutical Co., Ltd.'s share.



© Factset 2021
All news about CHUGAI PHARMACEUTICAL CO., LTD
05/26Chugai Launches Vabysmo Intravitreal Injection 120 mg/mL for the Treatment of Age-relat..
AQ
05/18Judgement On The First Drug Patent Linkage Lawsuit In China Is Issued
AQ
04/28Chugai Pharmaceutical Co., Ltd. - Notice of Completion of Disposal of Treasury Shares a..
AQ
04/27CHUGAI PHARMACEUTICAL : Notice of Completion of Disposal of Treasury Shares as Restricted ..
PU
04/26CHUGAI PHARMACEUTICAL : Script (including Q&A)
PU
04/26Chugai Pharmaceutical Co., Ltd. - Organizational and Personnel Changes
AQ
04/26Nikkei 225 Up 0.4% on Wall Street Cues, Softer Interest Rates, Oil Outlook
MT
04/26Chugai Pharmaceutical Logs 178% Surge in Q1 Net Income on Higher Sales
MT
04/25CHUGAI PHARMACEUTICAL : 1Q Results (Jan-Mar 2022)
PU
04/25Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces First Quarter Sales 20..
AQ
More news
Analyst Recommendations on CHUGAI PHARMACEUTICAL CO., LTD
More recommendations
Financials
Sales 2022 1 187 B 9 320 M 9 320 M
Net income 2022 343 B 2 690 M 2 690 M
Net cash 2022 604 B 4 742 M 4 742 M
P/E ratio 2022 16,5x
Yield 2022 2,26%
Capitalization 5 665 B 44 487 M 44 487 M
EV / Sales 2022 4,26x
EV / Sales 2023 4,74x
Nbr of Employees 7 664
Free-Float 37,8%
Chart CHUGAI PHARMACEUTICAL CO., LTD
Duration : Period :
Chugai Pharmaceutical Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHUGAI PHARMACEUTICAL CO., LTD
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 3 445,00 JPY
Average target price 4 677,69 JPY
Spread / Average Target 35,8%
EPS Revisions
Managers and Directors
Tatsuro Kosaka Manager-Pharmaceutical Business Strategy Office
Osamu Okuda Manager-Life Cycle Management II
Itagaki Toshiaki CFO, Manager-Information Technology & Accounting
Hisafumi Okabe Senior Executive Officer & Head-Research
Junichi Nezu Executive Officer, GM-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
CHUGAI PHARMACEUTICAL CO., LTD-7.76%44 487
JOHNSON & JOHNSON4.90%472 231
PFIZER, INC.-8.57%302 932
ROCHE HOLDING AG-12.16%282 336
ELI LILLY AND COMPANY13.48%282 164
ABBVIE INC.11.20%266 074